Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 21, 2017; 23(23): 4158-4169
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4158
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4158
Table 1 Chromosomal location of babA, babB and babC genes in different strains
| Strain | Locus A | Locus B | Locus C |
| 26695 | babB | babA | babC |
| J99 | babA | babB | No corresponding gene |
| HPAG1 | babA | babC | babB |
| G27 | babC | No corresponding gene | babA |
| 51 | babA | babB | No corresponding gene |
| Shi470 | babA | babB | No corresponding gene |
| P12 | babA | babB | babB homolog1 |
| 52 | babA | babB | No corresponding gene |
| B38 | babA | No corresponding gene | No corresponding gene |
| v225d | babA | babB | No corresponding gene |
| SJM180 | babB | babC | babA |
| PeCan4 | babA | babB | No corresponding gene |
| Sat464 | babA | babB | No corresponding gene |
| 35A | babA | babB | No corresponding gene |
| India7 | babA | babB | No corresponding gene |
| Gambia94/24 | babA | babB | No corresponding gene |
| SouthAfrica7 | babA | babA | No corresponding gene |
| Oki112 | babA | babA | No corresponding gene |
| Oki154 | babA | babB | No corresponding gene |
| Oki828 | babA | babA | No corresponding gene |
| J166 | babA | babB | No corresponding gene |
| SNT49 | babA | babB | No corresponding gene |
| Puno120 | babA | babB | No corresponding gene |
| Puno135 | babA | babB | No corresponding gene |
| B8 | babA | babA | No corresponding gene |
| 83 | babA | babB | No corresponding gene |
| ELS37 | babB | babA | No corresponding gene |
| HUP-B14 | babA | babC | No corresponding gene |
| F16 | babA | babB | No corresponding gene |
| F30 | babA | babB | No corresponding gene |
| Hp238 | babA | babB | No corresponding gene |
| BM013A | babB | babB | No corresponding gene |
| 29CaP | babA | babA | No corresponding gene |
Table 2 Prevalence of babA in different Asian and other countries
| Ref. | Countries | Criteria for babA positive | Prevalence | Year |
| Asia | ||||
| Abdullah et al[43] | Iraq | Positive with babA2 specific primers | 33.7% in NUD and 58.8% in PUD | 2012 |
| Karabiber et al[44] | Turkey | Positive with babA2 specific primers | 49% in gastritis | 2014 |
| Abadi et al[45] | Iran | Positive with babA2 specific primers | Overall-40.6% | 2013 |
| 95%-GC, 18.1-DU, 26.1-NUD | ||||
| Yadegar et al[46] | Iran | Positive with babA2 specific primers | Overall-96.7% | 2014 |
| 94.4%-NUD, 100%-PUD, 100%-GE, 100%-GC | ||||
| Saberi et al[42] | Iran | BabA expression | Overall-62% | 2016 |
| Osman et al[47] | Malaysia | Positive with babA2 specific primers | 41%-NUD | 2015 |
| Boonyanugomol et al[48] | Thailand | Positive with babA2 specific primers | Overall-66.2%, | 2012 |
| 70.7%-CCA, 54.5%-Cholelithiasis | ||||
| Chomvarin et al[49] | Thailand | Positive with babA2 specific primers | Overall-92% | 2008 |
| 92%-NUD, 85%-GU, 100%-DU, 94%-GC | ||||
| Ghosh et al[50] | India | Positive with babA2 specific primers | Overall-67.5% | 2016 |
| 65.6%-NUD, 70%-DU | ||||
| Con et al[51] | Japan | Positive with babA2 specific primers | Overall-96.8% | 2010 |
| Fujimoto et al[52] | Japan | Leb binding activity | Over all-88.0% | 2007 |
| Kim et al[32] | South Korea | Positive with babA specific primers | Overall-47.5% | 2015 |
| Other countries | ||||
| Kim et al[32] | United States | Positive with babA specific primers | Overall-90% | 2015 |
| Biernat et al[53] | Poland | Positive with babA2 specific primers | Overall-23.1% | 2014 |
| 18%-NUD, 30%-PUD, 31.8%-GERD | ||||
| Homan et al[54] | Slovenia | Positive with babA2 specific primers | Overall-47.9% | 2014 |
| Boyanova et al[55] | Bulgaria | Positive with babA2 specific primers | Overall-48.8% | 2010 |
| 59.3%-PUD, 43.5%-NUD | ||||
| Matteo et al[28] | Argentina | Positive with babA specific primers | Overall-67% | 2011 |
| Con et al[51] | Costa-Rica | Positive with babA2 specific primers | Overall-73.7% | 2010 |
| Fujimoto et al[52] | Colombia | Leb binding activity | Overall-83.0% | 2007 |
Table 3 BabA receptors found on oral cavity and in stomach
| Receptors identified | Localization | Ref. |
| Mucin MUC5B | Saliva | Walz et al[59] and Prakobphol et al[60] |
| Agglutinin glycoprotein-340 (gp-340) | Saliva | Prakobphol et al[61] |
| Prolin rich glycoprotein containing Fucα1-2Galβ motif | Saliva | Walz et al[59] |
| Secretory immunoglobulin A containing fucose-oligosaccharide motifs | Saliva | Borén et al[17] and Royle et al[62] |
| Salivary agglutinin DMBT1 | Saliva | Issa et al[63] |
| Lewis b blood group antigen (Leb) and terminal fucose, H1-antigen, A-antigen and B-antigen | Gastric epithelia | Borén et al[17] and McGuckin et al[64] |
| Mucin MUC5AC with N-acetylgalactosamine-β-1,4-N-acetylglucosamine | Gastric mucus | Lindén et al[68] and Kenny et al[69] |
| Mucin MUC1 | Gastric mucus | Lindén et al[71] |
| Mucin MUC2 | Gastric mucus | Cohen et al[72] |
Table 4 Oligosaccharides found in Leb involving in binding with amino acid of BabA
| Oligosaccharide in Leb | Amino acid in BabA | Position of amino acid in BabA |
| Fuc1 | Cysteine (C) | 189 |
| Fuc1 | Glycine (G) | 191 |
| Fuc1 | Asparagine (N) | 194 |
| Fuc4 | Asparagine (N) | 206 |
| GlcNAc3 or Gal5 | Aspartic acid (D) | 233 |
| Gal5 | Serine (S) | 234 |
| GlcNAc3 or Gal5 | Serine (S) | 244 |
| Fuc1 | Threonine (T) | 246 |
- Citation: Ansari S, Yamaoka Y. Helicobacter pylori BabA in adaptation for gastric colonization. World J Gastroenterol 2017; 23(23): 4158-4169
- URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4158.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i23.4158
